abstract |
The present invention includes at least one pharmaceutically acceptable excipient and an active pharmaceutical ingredient ("API") which is a compound of formula A1 or A2 or a pharmacologically acceptable salt, solvate or hydrate thereof, wherein the API is exposed to a basic compound To a solid phase pharmaceutical composition. |